Key Points
- Director Gregory Lucier bought 10,000 shares of Avantor at $8.32 each, totaling $83,200. After the purchase, he owned 60,000 shares, a 20% increase in his holdings.
- Avantor recently reported quarterly earnings of $0.17 per share, topping analyst estimates of $0.16, while revenue came in at $1.58 billion versus expectations of $1.54 billion.
- Analysts remain cautious on the stock: Avantor has a Hold consensus rating, with an average price target of $11.39, though several firms recently cut their targets or maintained underperform ratings.
Avantor, Inc. (NYSE:AVTR - Get Free Report) Director Gregory Lucier purchased 10,000 shares of Avantor stock in a transaction dated Friday, May 8th. The shares were bought at an average price of $8.32 per share, with a total value of $83,200.00. Following the completion of the acquisition, the director directly owned 60,000 shares of the company's stock, valued at approximately $499,200. This represents a 20.00% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Avantor Stock Performance
Shares of Avantor stock opened at $7.99 on Tuesday. The stock has a market cap of $5.45 billion, a price-to-earnings ratio of -9.86, a PEG ratio of 4.85 and a beta of 0.94. The firm's 50-day moving average is $8.06 and its 200 day moving average is $10.22. Avantor, Inc. has a 1 year low of $7.26 and a 1 year high of $15.93. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17.
Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.01. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. Avantor's revenue was up .0% compared to the same quarter last year. During the same period last year, the business earned $0.23 EPS. Sell-side analysts anticipate that Avantor, Inc. will post 0.79 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of AVTR. PNC Financial Services Group Inc. grew its stake in shares of Avantor by 83.7% during the 1st quarter. PNC Financial Services Group Inc. now owns 47,157 shares of the company's stock valued at $370,000 after purchasing an additional 21,481 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Avantor by 15.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 16,894,649 shares of the company's stock worth $132,443,000 after purchasing an additional 2,288,053 shares during the period. Parallel Advisors LLC boosted its holdings in shares of Avantor by 21.4% in the first quarter. Parallel Advisors LLC now owns 8,452 shares of the company's stock worth $66,000 after buying an additional 1,491 shares during the last quarter. Swiss National Bank grew its position in Avantor by 0.4% during the first quarter. Swiss National Bank now owns 1,349,400 shares of the company's stock valued at $10,579,000 after buying an additional 5,300 shares during the period. Finally, California Public Employees Retirement System increased its holdings in Avantor by 24.9% during the first quarter. California Public Employees Retirement System now owns 1,155,532 shares of the company's stock valued at $9,059,000 after buying an additional 230,183 shares during the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
AVTR has been the subject of a number of recent analyst reports. Stifel Nicolaus set a $10.00 price objective on shares of Avantor in a report on Thursday, February 12th. Jefferies Financial Group reissued an "underperform" rating and issued a $8.00 target price on shares of Avantor in a report on Thursday, February 12th. Citigroup decreased their price target on Avantor from $11.00 to $9.00 and set a "neutral" rating for the company in a research note on Thursday, April 30th. Barclays dropped their price objective on Avantor from $8.50 to $7.00 and set an "underweight" rating on the stock in a research report on Tuesday, April 14th. Finally, TD Cowen restated a "hold" rating on shares of Avantor in a research note on Thursday, February 12th. Three analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $11.39.
Get Our Latest Stock Report on Avantor
Avantor Company Profile
(
Get Free Report)
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor's offerings are organized across two primary segments.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
